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the cartilage. The purpose of the current study was to determine
the effect of IL-1 on global gene expression in chondrocytes from
individuals with no history of OA and chondrocytes from cartilage
with patients with OA.
Methods: Chondrocytes were isolated from cartilage of a donor
greater than 60 years without history of OA, intact cartilage from
total joint arthroplasty (OA) and a young adult without OA, and
cultured at 106 cells/cm2. IL-1 was added at concentrations of
2 ng/ml for some experiments and 0.1, 1 and 10 ng/ml for other
experiments. In some cultures IL-1 was removed at 24 hrs and
the anabolic factors BMP-2 and TGF-beta1 were added and
cultured for an additional 24 hrs. RNA was isolated by the Trizol
method and cDNA was prepared for microarray analysis using
cDNA arrays of 20,000 human gene transcripts. Microarray data
was verified using semi-quantitative RT-PCR.
Results: Microarray analysis suggested that a large set of
chemokine genes were the most highly responsive to IL-1 stim-
ulating begin increased 25-75 fold by 2 ng/ml (see Table 1). A
second set of chemokines was increased 3-11 fold. The increase
was observed down to a level of 100 pg/ml IL-1. As expected
type II collagen gene expression decreased by 50% and MMP-
13 expression increased 6 fold. Surprisingly, expression of the
aggrecanase, ADAMS-TS5, was present in all cartilages exam-
ined and down-regulated in normal cartilage by 7 fold and in
OA cartilage approximately 5 fold. All results were confirmed by
RT-PCR. BMP-2 was increased by 4 fold. IL-1 autoregulated its
own gene by 20 fold.
Table 1. Gene Expression (fold increase or decrease)
Gene Fold Increase or Decrease
Group 1:
CXCL2 (Gro-b)
CXCL8 (IL-8)
CXCL1 (Gro-1)
CCL4 (MIP-b)
CCL20 (MIP-3a) 25-75
CCL3L1 (LD78b)
CSCL6 (GCP-2)
IL-6CCL3 (MIP-1a)
CCL5 (RANTES)
CSCL5 (ENA-78)
CS3CL5 (Fractalkine) 3-11
CCL2 (MCP-1)
CCL8 (MCP-2)
MMP13 6
BMP-2 4
COL2A1 0.4
ADAMS-TS5 0.13
When the concentration of IL-1 was reduced to 100 pg/ml, the
chemokines were increased while the other effects of IL-1 were
reduced. The same result was observed in all ages of normal
cartilage. For the OA cartilage, gene expression was similar as
the low concentrations of IL-1, however, with addition of IL-1, the
effects were more dramatic. Interestingly, only TGF-BETA could
reverse some, but not all effects.
Conclusions: Two distinct sets of chemokines were the most
highly responsive of all cartilage genes to culture with IL-1. The
effects of IL-1 on other genes vary with the concentration of
the cytokine, but the chemokines are the most responsive. This
indicates that at these genes are differentially regulated. Sur-
prisingly, the aggrecanase gene ADAMS-TS5 was present in all
chondrocytes and down-regulated by IL-1. While the expected
effects of IL-1 were observed, other previously unknown effects
were observed. In addition, these experiments clearly demon-
strate that reactions vary by concentration. Thus even more
complex effects of inflammation on cartilage are revealed.
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Purpose: Calcitonin has been suggested to have chondropro-
tective effects in joint degenerative diseases. In vitro studies have
demonstrated that one signalling pathway of calcitonin is via the
second messenger cAMP. We investigated whether increased
cAMP levels in chondrocytes would be chondroprotective in a
model of cartilage degradation.
Methods: Cartilage degradation was induced in bovine articular
cartilage explants cultures by stimulation with 10 ng/mL onco-
statin M (OSM) and 20 ng/mL TNF. cAMP levels was stimulated
by treatment with either forskolin (cAMP activator, 1-64 μM) or
IBMX (phosphodiesterase inhibitor, 1-64 μM), and the intracellu-
lar cAMP levels were evaluated by ELISA. Cartilage degradation
was evaluated in the conditioned medium by quantification of
crosslinked C-telopeptide fragments of type II collagen (CTX-II),
matrix metalloproteinase (MMP) mediated aggrecan turnover by
a novel ELISA detecting the 342FFGVG-G2 cleavage site, ag-
grecanase mediated aggrecan turnover by a novel ARGS-G2
ELISA. Biochemical findings were validated by immunohisto-
chemistry of CTX-II fragments and toluidine blue stainings of
proteoglycans. Changes in MMP expression and activity in the
conditioned medium were assessed by gelatine zymography.
Alamarblue was used to evaluate cyto-toxicity after stimulation
with the various compounds and cytokines.
Results: OSM and TNF treatment induced a 500-fold increase
in CTX-II release to the supernatant (P<0.001) compared to
vehicle control. Both forskolin and IBMX dose-dependently in-
hibited CTX-II release (P<0.001), which at the highest concen-
tration was completely abrogated. OSM and TNF induced 8
fold increase in MMP mediated aggrecan degradation (FFGV-
G2), which was dose-dependently inhibited by both forskolin
and IBMX to 75%, (P<0.001). OSM and TNF evoked marked
increases in MMP expression, which was dose-dependently in-
hibited by both forskolin and IBMX. With regards to aggrecanase
activity, OSM and TNF induced a 4 fold increase in ARGS-
G2 degradation products of aggrecan. Forskolin significantly in-
hibited aggrecanase mediated aggrecan degradation by 60%
(P<0.01), whereas IBMX inhibited aggrecanase activity by 40%
albeit non-significant. None of the compounds affected cell num-
ber or viability.
Conclusions: cAMP levels in chondrocytes play a key role in
controlling the catabolic activity. Increased cAMP levels in chon-
drocytes results in inhibition of aggrecanase as well as MMP
expression and activity, and consequently a strong inhibition
of cartilage degradation. Specific cAMP modulators in chon-
drocytes, such as calcitonin, may be potential treatments for
cartilage degenerative diseases.
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Purpose: To investigate the effects of estrogen compared to
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that of traditional glucocorticosteroides for prevention of disease
progression of Collagen-Induced Arthritis (CIA) in rats and to
compare biochemical markers of cartilage degradation systemi-
cally in serum and locally in joint extracts to the degree of joint
erosion, paw swelling and joint score.
Methods: Fifty female Lewis rats (150-175g) were randomized
into 5 groups, and arthritis was induced in 4 groups by intrader-
mal injection of porcine type II collagen at the base of the tail on
day 0 and 7. One group was treated with 17-β-estradiol (0.18mg
pellet/60 days release) and two groups with a low or high dose of
oral prednisolone (0.6mg/kg/day or 3mg/kg/day). Disease onset
was registered as the first sign of swelling and redness of one
hind paw. Hind paw score (0-4, 4=most severe) and hind paw
volume was measured from day 8 after immunization. Urine and
serum was collected at baseline and 7, 14 and 21 days after
immunization. One hind paw was snap-frozen in liquid nitrogen,
homogenized and extracted for proteins, while the other hind
paw was fixated in formaldehyde and decalcified in EDTA for
histology and immunohistochemistry.
Levels of C-terminal telopeptides of type II collagen (CTX-II), C-
terminal telopeptides of type I collagen (CTX-I), tartrate-resistant
acid phosphatase (TRAP) and N-terminal propeptide of type
II collagen (PIINP) were measured in serum and in protein
extracts from control and diseased paws. Cartilage condition
was assessed by proteoglycan loss, osteophyte formation and
cartilage erosion in the tibiotarsal joint. Immunohistochemistry
was performed for the CTX-II epitope.
Results: In collagen injected non-treated animals, disease in-
cidence occurred from day 11 after the first collagen injection
and increased rapidly to 100% on day 15 (figure A). Estrogen
treatment both delayed disease onset and reduced disease oc-
currence by 43%. Both the high and low dose of prednisolone
efficiently prevented disease onset and progression (paw score
and paw volume). Compared to the control, the delta paw volume
on day 21 was significantly increased by 650% (p<0.001) in the
non-treated collagen-injected group, while estrogen treatment
significantly decreased this volume by 54% (p<0.01). These
changes in paw volume were accompanied in the serum by a
223% increase (P<0.001) in CTX-II levels from control to CIA-
group, and a 43% reduction from CIA-group to estrogen-group
(see figure B), indicating a correlation between paw volume as a
measure of disease pathology and serum CTX-II. In alignment,
prednisolone treatment resulted in a complete repression of CTX-
II values to control levels (p<0.001). Local joint pathology was
evaluated in paw extracts. CIA resulted in a 2000% increased
CTX-II level (P<0.01), which was significantly inhibited by both
estrogen and prednisolone. Immunohistochemistry showed that
CTX-II was localized to the eroded surface of articular cartilage.
Conclusions: Disease onset was associated with a marked
day-to-day increase in paw volume and paw score. Estrogen
Fig. A. Disease incidence in rats.
Fig. B. Serum CTX-II in rats – day 21.
significantly decreased disease incidence and progression, and
significantly haltered cartilage degradation evaluated by cartilage
degradation products, both locally and systemically. We suggest
that in addition to traditional methods used to access disease
progression, cartilage degradation products, which both can be
measured pre-clinically and clinically, can provide additional and
important information.
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Purpose: Chondrocyte apoptosis has been suggested to play
an important role in the pathogenesis of osteoarthritis (OA).
Numerous studies have reported a linear relationship between
apoptosis of articular chondrocytes and the degree of cartilage
degradation. However, it remains unclear whether chondrocyte
apoptosis is a cause of, or the result of, cartilage matrix break-
down. The aim of this study was to investigate the relationship
between early articular cartilage (AC) degeneration and chon-
drocyte apoptosis.
Methods: The study comprised AC taken from the left and right,
metacarpophalangeal (MCP) and metatarsophalangeal (MTP)
joints of 8 horses obtained from the local abattoir. The joints
were opened and the cartilage visually graded using a macro-
scopic OA grading system. Full depth AC was removed from six
specific sites across each joint; scores from each of these sites
were pooled in any analysis performed. For each horse, AC from
each of the 4 joints and from each sampling site was not always
available; this gave a total number of 149 cartilage specimens.
7μm cryostat sections were obtained. Haematoxylin and Eosin
with Safranin-O stained sections were used to score structural
differences between samples for features of cartilage pathol-
ogy using a ’modified’ Mankin scoring system. Apoptotic chon-
drocytes were identified using an indirect immunohistochemical
staining technique to detect the expression of active caspase-3
using a commercially available polyclonal antibody.
Results: Kruskal-Wallis with Dunn’s post test illustrated signifi-
cant differences in overall apoptosis when cartilage specimens
with a ‘modified’ Mankin score of 3 were compared to grade 2
(p<0.001**), grade 1 (p<0.001**) and grade 0 (p<0.05*) carti-
lage specimens. However no significant (ns) difference in overall
apoptosis was noted between grade 3 and grade 4 and 5 speci-
mens (Figure). The rate of apoptosis appears to increase linearly
from grade 0 to 3, but unchanged from grade 3-5. Similar findings
